Literature DB >> 27882550

Investigating interactions between epicardial adipose tissue and cardiac myocytes: what can we learn from different approaches?

Katja Rietdorf1, Hilary MacQueen1.   

Abstract

Heart disease is a major cause of morbidity and mortality throughout the world. Some cardiovascular conditions can be modulated by lifestyle factors such as increased exercise or a healthier diet, but many require surgical or pharmacological interventions for their management. More targeted and less invasive therapies would be beneficial. Recently, it has become apparent that epicardial adipose tissue plays an important role in normal and pathological cardiac function, and it is now the focus of considerable research. Epicardial adipose tissue can be studied by imaging of various kinds, and these approaches have yielded much useful information. However, at a molecular level, it is more difficult to study as it is relatively scarce in animal models and, for practical and ethical reasons, not always available in sufficient quantities from patients. What is needed is a robust model system in which the interactions between epicardial adipocytes and cardiac myocytes can be studied, and physiologically relevant manipulations performed. There are drawbacks to conventional culture methods, not least the difficulty of culturing both cardiac myocytes and adipocytes, each of which has special requirements. We discuss the benefits of a three-dimensional co-culture model in which in vivo interactions can be replicated. LINKED ARTICLES: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue - Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27882550      PMCID: PMC5610165          DOI: 10.1111/bph.13678

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  161 in total

1.  The effects of dietary lipids on dendritic cells in perinodal adipose tissue during chronic mild inflammation.

Authors:  Christine A Mattacks; Dawn Sadler; Caroline M Pond
Journal:  Br J Nutr       Date:  2004-06       Impact factor: 3.718

2.  Adult epicardial fat exhibits beige features.

Authors:  Harold S Sacks; John N Fain; Suleiman W Bahouth; Shalini Ojha; Andrea Frontini; Helen Budge; Saverio Cinti; Michael E Symonds
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

Review 3.  Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome.

Authors:  D I Siegel-Axel; H U Häring
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

4.  Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis.

Authors:  Martin Greif; Alexander Becker; Franz von Ziegler; Corinna Lebherz; Michael Lehrke; Uli C Broedl; Janine Tittus; Klaus Parhofer; Christoph Becker; Maximilian Reiser; Andreas Knez; Alexander W Leber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-19       Impact factor: 8.311

Review 5.  Investigating interactions between epicardial adipose tissue and cardiac myocytes: what can we learn from different approaches?

Authors:  Katja Rietdorf; Hilary MacQueen
Journal:  Br J Pharmacol       Date:  2017-01-22       Impact factor: 8.739

6.  Engineered neural tissue with aligned, differentiated adipose-derived stem cells promotes peripheral nerve regeneration across a critical sized defect in rat sciatic nerve.

Authors:  Melanie Georgiou; Jon P Golding; Alison J Loughlin; Paul J Kingham; James B Phillips
Journal:  Biomaterials       Date:  2014-10-23       Impact factor: 12.479

7.  The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease.

Authors:  Sandra Guauque-Olarte; Nathalie Gaudreault; Marie-Ève Piché; Dominique Fournier; Pascale Mauriège; Patrick Mathieu; Yohan Bossé
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

8.  Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels.

Authors:  Marios Margaritis; Alexios S Antonopoulos; Janet Digby; Regent Lee; Svetlana Reilly; Patricia Coutinho; Cheerag Shirodaria; Rana Sayeed; Mario Petrou; Ravi De Silva; Shapour Jalilzadeh; Michael Demosthenous; Constantinos Bakogiannis; Dimitris Tousoulis; Christodoulos Stefanadis; Robin P Choudhury; Barbara Casadei; Keith M Channon; Charalambos Antoniades
Journal:  Circulation       Date:  2013-04-26       Impact factor: 29.690

Review 9.  Calcium in the heart: from physiology to disease.

Authors:  David Eisner
Journal:  Exp Physiol       Date:  2014-08-15       Impact factor: 2.969

10.  Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease Patients.

Authors:  Atlanta G I M Elie; Pia S Jensen; Katrine D Nissen; Ilvy M E Geraets; Aimin Xu; Erfei Song; Maria L Hansen; Akhmadjon Irmukhamedov; Lars M Rasmussen; Yu Wang; Jo G R De Mey
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

View more
  3 in total

1.  Molecular mechanisms regulating perivascular adipose tissue - potential pharmacological targets?

Authors:  Simon Kennedy; Ian P Salt
Journal:  Br J Pharmacol       Date:  2017-10       Impact factor: 8.739

Review 2.  Investigating interactions between epicardial adipose tissue and cardiac myocytes: what can we learn from different approaches?

Authors:  Katja Rietdorf; Hilary MacQueen
Journal:  Br J Pharmacol       Date:  2017-01-22       Impact factor: 8.739

3.  Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability.

Authors:  Biao Li; Sunny S Po; Baojian Zhang; Fan Bai; Jiayi Li; Fen Qin; Na Liu; Chao Sun; Yichao Xiao; Tao Tu; Shenghua Zhou; Qiming Liu
Journal:  J Cell Mol Med       Date:  2020-05-22       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.